Case Studies

Discover how we’ve assisted global pharma and biotech companies in achieving their data objectives.

Filter

All Biomarkers Data Insights R&D Technology

Implementing an improved App Development Cycle for the Seven Bridges Platform

DNA strands

Advanced Target Profiling in Cancer – A Spatial and Single-Cell Transcriptomics Approach

DNA nucleus

Data driven disease-indication expansion and prioritization for specific target inhibitor

Excelra rare monogenic disease banner image

Data-Driven Solutions for Rare Monogenic Blood Disorders: Identifying and Prioritizing Treatment Compounds for Improved Patient Outcomes

Excelra case study on Rare Monogenic Blood Disorders

Empowering Client Success: Unveiling the Disease Landscape of Hyperphosphatemia

Enhancing Vegan Cheese Production: Leveraging Transcriptomic Data for Taste and Texture Improvement

Enhancing Vegan Cheese Production: Leveraging Transcriptomic Data for Taste and Texture Improvement

Personalized Psoriasis Treatment: A Case Study On How AI Accelerated Biomarker Discovery

Personalized Psoriasis Treatment: A Case Study On How AI Accelerated Biomarker Discovery

Optimizing Immunotherapy with Excelra's AI powered patient stratification

A Case Study On Optimizing Immunotherapy with Excelra’s AI-powered Patient Stratification

Building large Data assets allows MoA elucidation while keeping a view on competitive landscape

Building large Data assets allows MoA elucidation while keeping a view of the competitive landscape

Conquer COVID-19 Testing Challenges: In-Silico Design for Accurate NAAT Assays

Accelerating the Development of a Rapid Detection NAAT Assay for SARS-CoV2

Data migration

Seamless Data Migration to Benchling: A case study in biotech innovation

Tailoring an ELN for enhanced experiment management and data analysis

Filter

DNA strands

Biomarkers Data

Advanced Target Profiling in Cancer – A Spatial and Single-Cell Transcriptomics Approach

DNA nucleus

Biomarkers Data

Data driven disease-indication expansion and prioritization for specific target inhibitor

Excelra rare monogenic disease banner image

Data-Driven Solutions for Rare Monogenic Blood Disorders: Identifying and Prioritizing Treatment Compounds for Improved Patient Outcomes

Excelra case study on Rare Monogenic Blood Disorders

Empowering Client Success: Unveiling the Disease Landscape of Hyperphosphatemia

Enhancing Vegan Cheese Production: Leveraging Transcriptomic Data for Taste and Texture Improvement

Enhancing Vegan Cheese Production: Leveraging Transcriptomic Data for Taste and Texture Improvement

Unveiling the Molecular Code: Antibody Sequence Mining and Target Affinity Analysis

Landscape survey of non-small-cell lung carcinoma (NSCLC) for immuno-oncology (IO)

Patents are the Cornerstone for Advancing Data-Driven KRAS Drug Discovery

Screening adverse events related data

Building a text-miningbased post-translational modification (PTM) database for SUMOylation

Case of Dose Regimen Optimization for Paclitaxel

Experiments

Data-driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development

Filter

Implementing an improved App Development Cycle for the Seven Bridges Platform

Excelra rare monogenic disease banner image

Data-Driven Solutions for Rare Monogenic Blood Disorders: Identifying and Prioritizing Treatment Compounds for Improved Patient Outcomes

Excelra case study on Rare Monogenic Blood Disorders

Empowering Client Success: Unveiling the Disease Landscape of Hyperphosphatemia

Enhancing Vegan Cheese Production: Leveraging Transcriptomic Data for Taste and Texture Improvement

Enhancing Vegan Cheese Production: Leveraging Transcriptomic Data for Taste and Texture Improvement

Building large Data assets allows MoA elucidation while keeping a view on competitive landscape

Building large Data assets allows MoA elucidation while keeping a view of the competitive landscape

Conquer COVID-19 Testing Challenges: In-Silico Design for Accurate NAAT Assays

Accelerating the Development of a Rapid Detection NAAT Assay for SARS-CoV2

Unveiling the Molecular Code: Antibody Sequence Mining and Target Affinity Analysis

Identification of genomic biomarkers for cell line differentiation

Leveraging WES data to identify biomarker signatures

Custom annotation of public single-cell data offers opportunities for target identification

Fast and cost-effective whole-genome analysis

Re-analysing database for novel targets

Filter

All Biomarkers Data Insights R&D Technology

Implementing an improved App Development Cycle for the Seven Bridges Platform

Advanced Target Profiling in Cancer – A Spatial and Single-Cell Transcriptomics Approach

Data driven disease-indication expansion and prioritization for specific target inhibitor

Data-Driven Solutions for Rare Monogenic Blood Disorders: Identifying and Prioritizing Treatment Compounds for Improved Patient Outcomes

Empowering Client Success: Unveiling the Disease Landscape of Hyperphosphatemia

Enhancing Vegan Cheese Production: Leveraging Transcriptomic Data for Taste and Texture Improvement

Personalized Psoriasis Treatment: A Case Study On How AI Accelerated Biomarker Discovery

A Case Study On Optimizing Immunotherapy with Excelra’s AI-powered Patient Stratification

Building large Data assets allows MoA elucidation while keeping a view of the competitive landscape

Accelerating the Development of a Rapid Detection NAAT Assay for SARS-CoV2

Seamless Data Migration to Benchling: A case study in biotech innovation

Tailoring an ELN for enhanced experiment management and data analysis

Filter

Advanced Target Profiling in Cancer – A Spatial and Single-Cell Transcriptomics Approach

Data driven disease-indication expansion and prioritization for specific target inhibitor

Data-Driven Solutions for Rare Monogenic Blood Disorders: Identifying and Prioritizing Treatment Compounds for Improved Patient Outcomes

Empowering Client Success: Unveiling the Disease Landscape of Hyperphosphatemia

Enhancing Vegan Cheese Production: Leveraging Transcriptomic Data for Taste and Texture Improvement

Unveiling the Molecular Code: Antibody Sequence Mining and Target Affinity Analysis

Landscape survey of non-small-cell lung carcinoma (NSCLC) for immuno-oncology (IO)

Patents are the Cornerstone for Advancing Data-Driven KRAS Drug Discovery

Screening adverse events related data

Building a text-miningbased post-translational modification (PTM) database for SUMOylation

Case of Dose Regimen Optimization for Paclitaxel

Data-driven competitive landscape analysis to facilitate Go/No-Go decision in clinical development

Filter

Implementing an improved App Development Cycle for the Seven Bridges Platform

Data-Driven Solutions for Rare Monogenic Blood Disorders: Identifying and Prioritizing Treatment Compounds for Improved Patient Outcomes

Empowering Client Success: Unveiling the Disease Landscape of Hyperphosphatemia

Enhancing Vegan Cheese Production: Leveraging Transcriptomic Data for Taste and Texture Improvement

Building large Data assets allows MoA elucidation while keeping a view of the competitive landscape

Accelerating the Development of a Rapid Detection NAAT Assay for SARS-CoV2

Unveiling the Molecular Code: Antibody Sequence Mining and Target Affinity Analysis

Identification of genomic biomarkers for cell line differentiation

Leveraging WES data to identify biomarker signatures

Custom annotation of public single-cell data offers opportunities for target identification

Fast and cost-effective whole-genome analysis

Re-analysing database for novel targets

Copyright © 2024 Excelra All Rights Reserved. | Privacy Policy | Terms & Conditions